![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bioterrorism: Guidelines for Medical and Public Health
Management
Donald A Henderson, Thomas V Inglesby, and Tara
O’Toole (eds). Published by AMA Press, 2002. ISBN 1-57947-280-X. Contains
256 pages. Price US$29.95
This book provides a series of articles discussing six
potential bioterror agents or toxins that cause anthrax, smallpox, plague,
botulism, tularaemia, and viral hemorrhagic fevers; and how we can prepare for
public health disasters involving these agents. These agents are all
‘Category A’ agents because of their potentially devastating impact
on both individuals and society if used as agents of biologic warfare.
A strong public health system is needed to respond to
bioterrorism threats, however it is the early recognition by clinicians of
uncommon illnesses, which can provide the early alert that public health
emergency responses require. This in turn requires all front-line healthcare
professionals to be aware of the presentations of these diseases. The articles
included in this book, although previously published in JAMA prior to the events
of September 11, 2001, have been updated to provide up-to-date information
invaluable for healthcare professional education.
The anthrax attacks in the United States in 2001, and indeed
the ‘white powder’ incidents in New Zealand have given a new sense
of urgency to biodefence planning in many countries. Five case reports describe
in detail a number of the individual anthrax cases resulting from the 2001
attacks.
In his Foreword, Anthony Fauci states:
‘Much was learned
from the anthrax attacks of 2001; encouragingly, the survival rate of patients
with inhalation anthrax was considerably higher than previously reported,
perhaps due to rapid diagnosis, aggressive therapy with multidrug antibiotic
regimens, and state-of-the-art general medical supportive
care’.
Other potential bioterrorism agents are also considered
comprehensively. Their history, epidemiology, microbiology, pathogenesis and
clinical presentation, diagnosis, prevention, infection control, and medical
management are all covered and illustrated with some excellent photographs. The
discussion on the use of smallpox vaccine for mass vaccination and ring
vaccination is particularly relevant to New Zealand. With a limited stockpile of
vaccine, a focussed selective programme will be required.
Finally, bioterrorism preparedness and response are
analysed, including the scientific and legal implications of quarantine as a
possible public health tool in the event of a bioterror attack. Of critical
importance is the development of a public communication strategy to dispel
rumours and minimise social disruption.
This book tells us that, to effectively meet future public
health threats, all healthcare professionals must be alert and prepared. It has
some excellent illustrations, a comprehensive bibliography, and is a ‘must
read’ for clinicians, nurses, epidemiologists, public health specialists
and national and District Health Board (DHB) emergency planners.
Lance C Jennings
Clinical Virologist Canterbury Health Laboratories Canterbury District Health Board |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |